Get the Stockscreener App
0.76
1.67%
0.0125
After Hours:
.79
0.03
+3.95%
Moolec Science Sa stock is traded at $0.76, with a volume of 15,417.
It is up +1.67% in the last 24 hours and up +21.17% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
See More
Previous Close:
$0.7475
Open:
$0.749
24h Volume:
15,417
Relative Volume:
0.26
Market Cap:
$25.66M
Revenue:
$5.63M
Net Income/Loss:
$-7.31M
P/E Ratio:
-3.80
EPS:
-0.2
Net Cash Flow:
$-9.49M
1W Performance:
+18.49%
1M Performance:
+21.17%
6M Performance:
-13.64%
1Y Performance:
-46.10%
1-Day Range:
$0.6706
$0.76
1-Week Range:
$0.63
$0.78
52-Week Range:
$0.53
$1.43
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
0.76 | 25.66M | 5.63M | -7.31M | -9.49M | -0.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Moolec Science Stock to Reverse Split on Wednesday, May 14th (NASDAQ:MLEC) - Defense World
Moolec Science Announces Reverse Stock Split to Meet Nasdaq Requirements - TipRanks
Moolec Science announces shareholder-approved corporate changes - Investing.com Australia
Moolec Science announces shareholder-approved corporate changes By Investing.com - Investing.com Canada
Moolec Science Approves Strategic Redomiciliation to Cayman Islands - TipRanks
The largest local biotechnology company yields operations - indianetworknews.com
Moolec Science announces major all-stock merger - Investing.com
Moolec Science announces major all-stock merger By Investing.com - Investing.com South Africa
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms - eventsnewsasia.com
Moolec Science announces all-stock merger with Bioceres Grou By Investing.com - Investing.com Canada
Moolec Science SA Enters Business Combination Deal With Bioceres Group Limited - marketscreener.com
Small Cap Stock Moolec Science SA (MLEC) Is A Buy – Analysts - Marketing Sentinel
Moolec Science Announces Transformational Business Combination with Bioceres Group - TipRanks
Moolec Science announces all-stock merger with Bioceres Grou - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Moolec Science Announces Business Combination - Investing.com Australia
Moolec Science Announces Business Combination By Investing.com - Investing.com South Africa
Moolec Science Announces Strategic Business Combination with Bioceres Group - TipRanks
Moolec Science (NASDAQ:MLEC) Trading Down 1.2% – What’s Next? - Defense World
Moolec Science (NASDAQ:MLEC) Shares Down 1.2% – Should You Sell? - American Banking and Market News
Moolec Science SA reports results for the quarter ended December 31Earnings Summary - TradingView
Moolec Science Reports Financial Results for December 2024 - TipRanks
Leadership Changes at Moolec Science as CEO and Board Members Resign - TipRanks
Moolec Science Plans Strategic Relocation and Board Appointments - TipRanks
Moolec Science receives Nasdaq compliance extension By Investing.com - Investing.com Australia
Moolec Science Granted Temporary Nasdaq Compliance Exception - TipRanks
Moolec Science receives Nasdaq compliance extension - Investing.com
Moolec Science (NASDAQ:MLEC) Stock Price Up 5% – Should You Buy? - Defense World
Quantum FinTech Acquisition (NYSE:QFTA) and Moolec Science (NASDAQ:MLEC) Financial Contrast - Defense World
Moolec Received Nasdaq Staff Determination Letter - Big News Network
Moolec Science Appeals Nasdaq Delisting Notice - MSN
Moolec Science faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
Moolec Science faces Nasdaq delisting over share price - Investing.com
Moolec Science (MLEC) Stock Price, News & Analysis - MarketBeat
Moolec Science (MLEC) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update - ACCESS Newswire
Why Shares Of Moolec Science Are Skyrocketing Today - MSN
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):